Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

7.11
-0.39
(-5.20%)
As of 3:16:28 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
--
--
881.71
Operating Expense
48,721
48,721
45,078
34,835.45
56,870.73
Operating Income
-48,721
-48,721
-45,078
-34,835.45
-55,989.02
Net Non Operating Interest Income Expense
4,439
4,439
-2,222
-2,132.09
-1,830.49
Other Income Expense
4,073
4,073
2,696
-5,379.37
12,179.08
Pretax Income
-40,209
-40,209
-44,604
-42,346.90
-45,640.43
Net Income Common Stockholders
-40,209
-40,209
-44,604
-42,346.90
-45,640.43
Diluted NI Available to Com Stockholders
-40,209
-40,209
-44,604
-42,346.90
-45,640.43
Basic EPS
-4.71
-3.68
-10.31
-10.15
-11.10
Diluted EPS
-4.71
-3.68
-10.31
-10.15
-11.10
Basic Average Shares
8,974.42
10,915.41
4,327.57
4,170.67
4,099.67
Diluted Average Shares
8,974.42
10,915.41
4,327.57
4,170.67
4,099.67
Total Operating Income as Reported
-48,721
-48,721
-45,078
-39,835.45
-55,989.02
Total Expenses
48,721
48,721
45,078
34,835.45
56,870.73
Net Income from Continuing & Discontinued Operation
-40,209
-40,209
-44,604
-42,346.90
-45,640.43
Normalized Income
-40,209
-40,209
-44,604
-37,016.31
-45,919.52
Interest Income
6,311
6,311
1,636
--
--
Interest Expense
1,872
1,872
3,858
--
--
Net Interest Income
4,439
4,439
-2,222
-2,132.09
-1,830.49
EBIT
-38,337
-38,337
-40,746
-34,835.45
-55,989.02
EBITDA
-37,749
-37,749
-40,105
-34,072.45
-54,349.79
Reconciled Depreciation
588
588
641
763
1,639.23
Net Income from Continuing Operation Net Minority Interest
-40,209
-40,209
-44,604
-42,346.90
-45,640.43
Total Unusual Items Excluding Goodwill
--
--
8.52
-5,330.59
279.09
Total Unusual Items
--
--
8.52
-5,330.59
279.09
Normalized EBITDA
-37,749
-37,749
-40,105
-28,741.86
-54,628.88
12/31/2021 - 10/27/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

JANX Janux Therapeutics, Inc.
32.24
+0.03%
 
RGNX REGENXBIO Inc.
9.41
+3.07%
 
TIL Instil Bio, Inc.
11.71
-5.87%
 
RPTX Repare Therapeutics Inc.
1.3350
-1.84%
 
ATXS Astria Therapeutics, Inc.
5.14
+3.63%
 
GPCR Structure Therapeutics Inc.
25.83
+9.34%
 
VERV Verve Therapeutics, Inc.
5.57
-2.88%
 
JAGX Jaguar Health, Inc.
12.22
+14.53%
 
VYNE VYNE Therapeutics Inc.
1.3900
-3.47%
 
CRDF Cardiff Oncology, Inc.
2.8450
-3.56%